JONACIPRO

This brand name is authorized in Nigeria.

Active ingredients

The drug JONACIPRO contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-1455	Tablet	Jonacipro Tablets 500 mg (duplicate) TAB 500 mg 1 x 10's (in PVC-Alu blister)	Tablet JONACIPRO TABLETS 500MG CIPROFLOXACIN HYDROCHLORIDE USP 500MG ACTIVE: Ciprofloxacin Hydrochloride USP 500mg LIST OF EXCIPIENTS: Cellulose microcrystalline Sodium starch glycolate Povidone Silica, colloidal anhydrous Magnesium stearate C4-1455 Drugs Imported Products 110 Prescription Only Medicine (POM) 12/07/2023 JONA PHARMACY AND GENERAL ENTERPRISES NIGERIA LIMITED, NO.100,NIGER ROAD, SABON GARI, KANO, KANO STATE 8068244299 juche099@gmail.com VARDHMAN EXPORTS, A-188, T.T.C. M.I.D.C INDL. AREA, KHAIRNE, NAVI MUMBAI-400710. MAHARASHTRA STATE, INDIA, India	21/12/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-1455